Showing results (261-270 of 270) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 270 results.
The British Journal of Surgery|March 1, 1995
Improved outcome for children with hepatoblastomaM D Stringer, S Hennayake, E R Howard, et al.
European Journal of Pediatrics|December 14, 1999
Sacral dysgenesis associated with terminal deletion of chromosome 7q: a report of two familiesJ Wang, L Spitz, R Hayward, et al.
Journal of Pediatric Surgery|May 3, 2002
T cryptantigen activation is associated with advanced necrotizing enterocolitisN Hall, E G p Ong, N Ade-Ajayi, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|May 31, 2026
The TRAINE Program for Networking T32 Cancer Prevention Fellows Across Institutions: a Preliminary ReportJ P Wisnivesky, M McVeety, B F Fuemmeler, et al.
The New England Journal of Medicine|April 2, 2015
Cell-free DNA analysis for noninvasive examination of trisomyMary E Norton, Bo Jacobsson, Geeta K Swamy, et al.
JCO Clinical Cancer Informatics|December 10, 2025
Patient Portal Engagement in Oncology: Results From the NU IMPACT Study in a Large Health Care SystemKyle M Nolla, Maja Kuharic, Nicola Lancki, et al.
Physical Review Letters|March 5, 2004
Isospin diffusion and the nuclear symmetry energy in heavy ion reactionsM B Tsang, T X Liu, L Shi, et al.
Gynecologic Oncology|September 29, 2016
Phase II study of Vigil® DNA engineered immunotherapy as maintenance in advanced stage ovarian cancerJonathan Oh, Minal Barve, Carolyn M Matthews, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2021
Adavosertib with Chemotherapy in Patients with Primary Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer: An Open-Label, Four-Arm, Phase II StudyKathleen N Moore, Setsuko K Chambers, Erika P Hamilton, et al.
Gynecologic Oncology|June 4, 2024
Long-term follow-up of efficacy and safety of selinexor maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO studyVicky Makker, Jose Alejandro Perez-Fidalgo, Giorgio Valabrega, et al.
Pageof 27